QTc interval correction
The QT interval shortens at faster heart rates and lengthens when the heart slows. QTc corrects for that, letting you compare intervals across different rates. Four formulas are widely used. None is perfect, and they diverge most at extreme heart rates. Because QTc is also sensitive to serum electrolytes, converting lab values reported in different units (our Lab Values Converter handles potassium and magnesium in mmol/L vs mEq/L) matters just as much as picking the right formula.
Which formula to use
Bazett is everywhere. Drug labels quote it, hospital systems use it, and most clinicians know the thresholds. Its weakness is overcorrection at fast rates and undercorrection below 60 bpm. At normal heart rates (60-100 bpm) the difference between formulas is clinically negligible.
The European Medicines Agency's ICH E14 guideline recommends Fridericia for formal drug safety studies. If you're evaluating drug-induced QT prolongation in a tachycardic patient, Fridericia gives a more reliable number.
Common QT-prolonging drugs
Antipsychotics (haloperidol, quetiapine), antidepressants (citalopram, tricyclics), antibiotics (azithromycin, moxifloxacin), antiemetics (ondansetron, domperidone), and antiarrhythmics (amiodarone, sotalol) all carry QT risk. Check CredibleMeds for drug-specific risk classification. Hypokalaemia and hypomagnesaemia compound the risk significantly.
Renal function and QT-prolonging drugs
Several QT-prolonging drugs (sotalol, dofetilide, and some macrolides) are renally cleared and accumulate in kidney impairment, increasing QTc risk independent of the drug's baseline QT effect. Checking Creatinine Clearance before starting or renewing one of these agents is a reasonable safeguard alongside a baseline ECG.
Frequently Asked Questions
Why do the four formulas give different QTc values?
What should I do if the QTc is prolonged?
Do low potassium and magnesium really affect QTc?
Related tools
For 10-year CVD risk, see Framingham Risk Score. For ACS risk in chest pain, see HEART Score.
References
- Bazett HC. "An analysis of the time-relations of electrocardiograms." Heart. 1920;7:353-370.
- Fridericia LS. "Die Systolendauer im Elektrokardiogramm." Acta Med Scand. 1920;53:469-486.
- European Medicines Agency. ICH E14 Guideline: QT/QTc interval prolongation. EMA, 2005.